High-intensity exercise | ||||||||
---|---|---|---|---|---|---|---|---|
Women with FM, n = 22 | Healthy reference group, n = 27 | Between-group differences | ||||||
0 min | 15 min–0 min | 0 min | 15 min–0 min | 0 min | Change 0–15 min | |||
Mean ± sd | ∆ mean ± sd | p-value | Mean ± sd | ∆ mean ± sd | p-value | p-value | p-value | |
S-IGF-1 (ng/ml) | 195 ± 60 | 11 ± 15 | <0.001 | 181 ± 66 | 19 ± 22 | <0.001 | 0.244 | 0.560 |
Free IGF-1 (ng/ml) | 4.7 ± 2.6 | −0.42 ± 0.48 | 0.014 | 4.7 ± 3.2 | −0.56 ± 0.76 | <0.001 | 0.755 | 0.843 |
S-IGFBP3 (ng/ml) | 556 ± 75 | 25 ± 37 | 0.009 | 614 ± 91 | 25 ± 41 | 0.008 | 0.037 | 0.942 |
sCRP μg/ml) | 2.1 ± 2.4 | 0.06 ± 0.16 | 0.002 | 0.70 ± 0.77 | 0.04 ± 0.06 | <0.001 | 0.001 | 0.119 |
IL-8 (pg/ml) | 7.5 ± 3.0 | 0.7 ± 2.9 | 0.545 | 9.7 ± 4.2 | −0.2 ± 1.9 | 0.673 | 0.107 | 0.565 |
Pain (0–100, mm) | 46 ± 24.4 | −4.0 ± 16.1 | 0.291 | 2.4 ± 7.4 | 0 ± 3.6 | 0.878 | <0.001 | 0.139 |
Fatigue in legs (0–100 mm) | 31 ± 21 | 28 ± 20 | <0.001 | 1.2 ± 3.1 | 12 ± 13 | <0.001 | <0.001 | 0.003 |
Fatigue global (0–100 mm) | 50 ± 24 | 8.4 ± 19 | 0.007 | 3.0 ± 5.3 | 6.3 ± 10 | <0.001 | <0.001 | 0.414 |